[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Correction
May 9, 2017

Incorrect Unit of Measure

JAMA. 2017;317(18):1912. doi:10.1001/jama.2017.4657

In the Original Investigation entitled “Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial” published in the January 24/31, 2017, issue of JAMA,1 the article reported an incorrect unit of measure. In the Hypoglycemia subsection of Results, the second and third sentences should read “There were 5 events of severe hypoglycemia during conventional treatment (event rate, 0.19 per 1000 patient-days) and 1 event occurred during CGM therapy (event rate, 0.04 per 1000 patient-days). There were 7 severe hypoglycemia events during the washout period when patients were undergoing conventional therapy (event rate, 0.41 per 1000 patient-days).” This article was corrected online.

References
1.
Lind  M, Polonsky  W, Hirsch  IB,  et al.  Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections.  JAMA. 2017;317(4):379-387.PubMedGoogle ScholarCrossref
×